Studies: J&J vax reduces severe omicron infection by 85%

On Thursday, Johnson & Johnson released new data showing that its COVID-19 vaccine and booster shot offers significant protection against hospitalization caused by the omicron variant.

Related Keywords

Boston ,Massachusetts ,United States ,South Africa ,White House ,District Of Columbia ,Americans ,Johnson ,Mathai Mammen ,Beth Israel Deaconess Medical Center ,J Ampj Booster ,Johnson Amp ,Johnson Amp Booster ,Johnson Amp Shots ,Johnson Amp Vaccine ,J Ampj Vaccine ,Vaccines ,